April 13, 2022
This colorectal cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
April 13, 2022
This colorectal cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
April 13, 2022
This colorectal cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
April 13, 2022
This colorectal cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
April 13, 2022
This colorectal cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
April 13, 2022
This colorectal cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
April 13, 2022
This colorectal cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.